|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to cash used in operating activities: | |||||
| Depreciation expense | |||||
| Amortization of debt discounts and issuance costs | |||||
| Stock-based compensation expense | |||||
| Gain (Loss) on Extinguishment of Debt | |||||
| Change in fair value of warrant liability | |||||
| Change in operating lease right of use assets | |||||
| Change in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liabilities | |||||
| Cash used in operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Cash used in investing activities | |||||
| Financing activities: | |||||
| Advances from employees | |||||
| Repayment of advances from employees | |||||
| Proceeds from issuance of non-convertible promissory note | |||||
| Repayment of non-convertible promissory note | |||||
| Proceeds from issuance of bridge promissory note | |||||
| Proceeds from warrant exercise | |||||
| Payment for fractional shares in connection with reverse stock split | |||||
| Cash acquired in reverse recapitalization | |||||
| Payment of reverse recapitalization costs | |||||
| Payment of debt issuance costs | |||||
| Redemption of redeemable common stock | |||||
| Cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure or noncash activities: | |||||
| Cash paid for interest | |||||
| Issuance of stock for repayment of bridge loan | |||||
| Non-contingent beneficial conversion feature on convertible promissory note | |||||
| Restricted stock awards issued in satisfaction of accrued compensation | |||||
| Recognition of debt discount and additional paid-in-capital for warrants issued in connection with promissory notes | |||||
| Net liabilities acquired in connection with reverse recapitalization | |||||
| Conversion of promissory note | |||||
| Stock issuance costs included in accounts payable | |||||
| Issuance of stock for payment of reverse recapitalization costs | |||||
| Issuance of warrants for payment of stock issuance costs | |||||
Loading...